104P Camrelizumab combined with chemotherapy and apatinib as first-line therapy for extensive-stage small cell lung cancer: A phase II single-arm, exploratory research. (December 2022) - Zhao, Y.; Wang, X.; Zhang, M.; Liu, J.; Pu, H.; Li, X.; Zhao, H.; Xu, S.; Yang, M.; Bai, S.; Guo, L.; Zhao, L.; et al.